Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2016
Committee Review
Floor Vote
Governor
Introduced May 23, 2016
Last action Oct 20, 2016
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
1
Committee
1
Oct 6, 2016
Legislature · Passed
Reported out of Assembly Committee, 2nd Reading
legislature
May 23, 2016
Introduced
Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee
legislature
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about A 3793
Scope: NJ
Hi! I can help you understand A 3793. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline